Genscript Biotech Corporation (1548.HK)

HKD 11.04

(-1.43%)

Total Assets Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual total assets in 2023 was 3.38 Billion USD , up 33.02% from previous year.
Genscript Biotech Corporation's latest quarterly total assets in 2024 Q2 was 3.33 Billion USD , down -1.64% from previous quarter.
Genscript Biotech Corporation reported annual total assets of 2.54 Billion USD in 2022, up 13.99% from previous year.
Genscript Biotech Corporation reported annual total assets of 2.23 Billion USD in 2021, up 54.34% from previous year.
Genscript Biotech Corporation reported quarterly total assets of 3.38 Billion USD for 2023 FY, up 33.02% from previous quarter.
Genscript Biotech Corporation reported quarterly total assets of 3.38 Billion USD for 2023 Q4, up 0.09% from previous quarter.

Annual Total Assets Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Total Assets of Genscript Biotech Corporation (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	3.38 Billion USD	33.02%
2022	2.54 Billion USD	13.99%
2021	2.23 Billion USD	54.34%
2020	1.44 Billion USD	62.74%
2019	889.41 Million USD	-3.01%
2018	916.97 Million USD	81.84%
2017	504.26 Million USD	123.09%
2016	226.03 Million USD	24.14%
2015	182.07 Million USD	97.09%
2014	92.38 Million USD	10.19%
2013	83.83 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	3.33 Billion USD	-1.64%
2023 FY	3.38 Billion USD	33.02%
2023 Q4	3.38 Billion USD	0.09%
2023 Q2	3.38 Billion USD	32.91%
2022 FY	2.54 Billion USD	13.99%
2022 Q4	2.54 Billion USD	18.75%
2022 Q2	2.14 Billion USD	-4.01%
2021 Q4	2.23 Billion USD	18.32%
2021 FY	2.23 Billion USD	54.34%
2021 Q2	1.88 Billion USD	30.44%
2020 Q2	1.43 Billion USD	61.88%
2020 Q4	1.44 Billion USD	0.53%
2020 FY	1.44 Billion USD	62.74%
2019 FY	889.41 Million USD	-3.01%
2019 Q2	881.95 Million USD	-3.82%
2019 Q4	889.41 Million USD	0.85%
2018 Q4	916.97 Million USD	2.15%
2018 FY	916.97 Million USD	81.84%
2018 Q2	897.67 Million USD	78.02%
2017 Q4	504.26 Million USD	105.35%
2017 FY	504.26 Million USD	123.09%
2017 Q2	245.56 Million USD	8.64%
2016 FY	226.03 Million USD	24.14%
2016 Q4	226.03 Million USD	5.45%
2016 Q2	214.35 Million USD	17.73%
2015 FY	182.07 Million USD	97.09%
2015 Q2	94.17 Million USD	1.94%
2015 Q4	182.07 Million USD	93.35%
2014 FY	92.38 Million USD	10.19%
2014 Q4	92.38 Million USD	0.0%
2013 FY	83.83 Million USD	0.0%

Peer Total Assets Comparison of Genscript Biotech Corporation

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-726.187%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	69.884%